Literature DB >> 15743033

P21 and Bax expression in cutaneous malignant melanomas: correlation with histologic prognostic parameters.

A Poyraz1, N Akyürek, I I Gönül, O Erdem.   

Abstract

In response to DNA damage, p53 accumulates and regulates expression of several genes, including cyclin-dependent kinase inhibitor p21. Cells then undergo p21 dependent cell cycle arrest, which allows DNA damage repair and apoptosis. Bax is a death promoter member of the bcl-2 family which plays a central role in the regulation and commitment to programmed cell death. Breslow thickness is the most important factor in predicting prognosis for cutaneous malignant melanoma. In order to define the role of cyclin dependent kinase inhibitors and apoptosis regulators in invasion of malignant melanoma we investigated the expression of p21 and bax proteins. We observed that significant high p21 expression was associated with increasing Breslow thickness (Spearman correlation analysis, p=0.01). Additionally, Clark level I and II tumours expressed significantly lower p21 positivity than Clark level III, IV and V (p=0.006). Similarly, thick tumors showed a higher bax expression (p=0.012). Our results suggested that the role of p21 expression is more complicated in melanocytic skin cancers and abnormal regulation or abnormal function of cell cycle regulators occurred in the development and progression of malignant melanoma. In order to understand the role of bax expression in thick malignant melanomas and invasion biology, comparative analytic studies with other apoptosis regulators are needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15743033

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  4 in total

1.  Immunohistochemical expression of p16, p21, p27 and cyclin D1 in oral nevi and melanoma.

Authors:  Bruno Augusto Benevenuto de Andrade; Jorge Esquiche León; Román Carlos; Wilson Delgado-Azañero; Adalberto Mosqueda-Taylor; Oslei Paes de Almeida
Journal:  Head Neck Pathol       Date:  2012-02-05

2.  A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines.

Authors:  Craig Carson; Bernard Omolo; Haitao Chu; Yingchun Zhou; Maria J Sambade; Eldon C Peters; Patrick Tompkins; Dennis A Simpson; Nancy E Thomas; Cheng Fan; Alain Sarasin; Philippe Dessen; Janiel M Shields; Joseph G Ibrahim; William K Kaufmann
Journal:  Pigment Cell Melanoma Res       Date:  2012-06-01       Impact factor: 4.693

3.  Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.

Authors:  Bonnie E Gould Rothberg; David L Rimm
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

4.  Antineoplastic Effects of Honokiol on Melanoma.

Authors:  Ruth Guillermo-Lagae; Sreevidya Santha; Milton Thomas; Emily Zoelle; Jonathan Stevens; Radhey S Kaushik; Chandradhar Dwivedi
Journal:  Biomed Res Int       Date:  2017-01-17       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.